SCHEMBL197285

SCHEMBL197285

C[Si](c1ccccc1)(c1ccccc1)c1ccc(-c2ccc([Si](C)(c3ccccc3)c3ccccc3)cn2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 4/20 0.39
CCR8 P51685 4/20 0.39
CCR5 P51681 3/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
NR1H2 P55055 2/20 0.35
NR1H3 Q13133 2/20 0.35
P4HTM Q9NXG6 3/20 0.34
P4HA1 P13674 1/20 0.34
LDHA P00338 2/20 0.33
IDO1 P14902 1/20 0.33
TDO2 P48775 1/20 0.33
BAZ2B Q9UIF8 1/20 0.33
KDM4E B2RXH2 3/20 0.32
LMNA P02545 3/20 0.32
TP53 P04637 2/20 0.32
ALOX15 P16050 2/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2989980 0.91 KDM4E (0.50) CCR1CCR8CCR5P4HTMTDO2
SCHEMBL198141 0.83 ESR1 (0.54) CCR1CCR8CCR5HDAC6ESR1
SCHEMBL196196 0.79 ESR1 (0.36) ESR1ESR2NR1H2NR1H3SMN1; SMN2
SCHEMBL439492 0.78 ESR1 (0.48) CCR1CCR8ESR1ESR2NR1H2
SCHEMBL193465 0.77 CCR1 (0.37) CCR1CCR8CCR5HDAC6ESR1
SCHEMBL2986923 0.75 KDM4E (0.50) CCR1CCR8CCR5ESR1ESR2
SCHEMBL4381210 0.75 CCR1 (0.44) CCR1CCR8CCR5HDAC6P4HTM
SCHEMBL195553 0.74 CCR1 (0.48) CCR1CCR8CCR5HDAC6NR1H2
SCHEMBL29505097 0.72 LDHA (0.48) LDHAIDO1TDO2BAZ2BHPGDS
SCHEMBL17780846 0.72 LDHA (0.48) LDHAIDO1TDO2BAZ2BHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088883-B2 Transition metal complex and process for producing conjugated aromatic compound using the transition metal complex SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-03 US disclosed
US-20110046336-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED 2011-02-24 US disclosed
EP-2192124-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND WITH THE TRANSITION METAL COMPLEX Sumitomo Chemical Company, Limited (JP) 2010-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046336-A1 TRANSITION METAL COMPLEX AND PROCESS FOR PRODUCING CONJUGATED AROMATIC COMPOUND USING THE TRANSITION METAL COMPLEX C9, C5, AP1M1 CCR1 510/4885CCR8 2317/4885CCR5 948/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.